New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2013
08:14 EDTNXTMNxStage Medical announces CE Mark approval for noctural home hemodialysis
NxStage Medical announced CE Mark approval for nocturnal home hemodialysis with the NxStage System One. NxStage expects to begin marketing the System One for nocturnal dialysis in countries that recognize the CE Mark approval process in the second half of 2013.
News For NXTM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 10, 2016
08:06 EDTNXTMNxStage Medical sees Q1 revenue $87M-$89M, consensus $89.3M
Subscribe for More Information
08:06 EDTNXTMNxStage Medical sees FY16 revenue $355M-$360M, consensus $371.03M
Sees FY16 net loss in range of $7M-$12M. The company commented, "Our guidance for the full fiscal year 2016 includes continued strong performance from our System One segment, with expectations for annual growth within Home and Critical Care of 15 percent and 9 percent, respectively, and a modest increase in our Services segment. We've also guided to a much lower revenue level for our low margin In-Center segment."
08:05 EDTNXTMNxStage Medical reports Q4 EPS (4c), consensus (4c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use